feed,title,long_url,short_url
SeekingAlpha,Journey Medical climbs 21% after Phase 1 data for skin disease candidate,https://seekingalpha.com/news/3979558,
SeekingAlpha,Cadence to buy back $200M stock under ASR agreement,https://seekingalpha.com/news/3979556,
